{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:56:18Z","timestamp":1788814578638,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100023238","name":"Victoria General Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022499","name":"Janet D. Cottrelle Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022499","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijgc.2025.101635","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T19:21:46Z","timestamp":1736796106000},"page":"101635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-4457","authenticated-orcid":false,"given":"Evan","family":"Gibbard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-9351","authenticated-orcid":false,"given":"Dawn R.","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramlogan","family":"Sowamber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Huvila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-8589","authenticated-orcid":false,"given":"Amanda S.","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Greening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissreen","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Farnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wren S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-8250","authenticated-orcid":false,"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijgc.2025.101635_bib1","unstructured":"Navaneelan T. Trends in the incidence and mortality of female reproductive system cancers. Health at a glance. Statistics Canada. Accessed March 19, 2024. https:\/\/www150.statcan.gc.ca\/n1\/pub\/82-624-x\/2015001\/article\/14095-eng.htm."},{"key":"10.1016\/j.ijgc.2025.101635_bib2","unstructured":"Ovarian cancer statistics. World Cancer Research Fund International. Accessed February 27, 2024. https:\/\/www.wcrf.org\/cancer-trends\/ovarian-cancer-statistics\/."},{"issue":"11","key":"10.1016\/j.ijgc.2025.101635_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/cancers10110433","article-title":"Cell origins of high-grade serous ovarian cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101635_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"4","key":"10.1016\/j.ijgc.2025.101635_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.ijgc.2025.101635_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101635_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101635_bib8","doi-asserted-by":"crossref","first-page":"E466","DOI":"10.9778\/cmajo.20210219","article-title":"Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis","volume":"10","author":"Hanley","year":"2022","journal-title":"CMAJ Open"},{"key":"10.1016\/j.ijgc.2025.101635_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejogrb.2018.03.043","article-title":"Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: what do national societies advise?","volume":"225","author":"Ntoumanoglou-Schuiki","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101635_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijgc.2025.101635_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/126295","article-title":"Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics","volume":"2010","author":"Gross","year":"2010","journal-title":"J Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101635_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101635_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101635_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101635_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"K\u00f6bel","year":"2016","journal-title":"J Pathol Clin Res"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101635_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Yemelyanova","year":"2011","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101635_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101635_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The origin of ovarian cancer species and precancerous landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101635_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the Fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101635_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101635_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101635_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijgc.2025.101635_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101635_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41379-019-0370-1","article-title":"Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions","volume":"33","author":"Wu","year":"2020","journal-title":"Mod Pathol."},{"issue":"11","key":"10.1016\/j.ijgc.2025.101635_bib25","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.celrep.2017.02.049","article-title":"Progesterone prevents high-grade serous ovarian\u00a0cancer by inducing necroptosis of p53-defective Fallopian tube epithelial cells","volume":"18","author":"Wu","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101635_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","article-title":"Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma","volume":"132","author":"Bahar-Shany","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101635_bib27","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/diagnostics12123054","article-title":"Pathologic findings at risk reducing surgery in BRCA and non-BRCA mutation carriers: a single-center experience","volume":"12","author":"Cassani","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101635_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria\u00a0and\u00a0pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J\u00a0Surg Pathol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101635_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101635_bib30","doi-asserted-by":"crossref","first-page":"19257","DOI":"10.3390\/ijms140919257","article-title":"The consequence of oncomorphic TP53 mutations in ovarian cancer","volume":"14","author":"Brachova","year":"2013","journal-title":"Int J Mol Sci."},{"issue":"11","key":"10.1016\/j.ijgc.2025.101635_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian tube lesions in women at high risk for ovarian cancer: a multicenter study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101635_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.gie.2024.05.021","article-title":"Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis","volume":"100","author":"Baile-Max\u00eda","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"suppl 2","key":"10.1016\/j.ijgc.2025.101635_bib33","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/modpathol.3800509","article-title":"Squamous cell carcinoma: from precursor lesions to high-risk variants","volume":"19","author":"Smoller","year":"2006","journal-title":"Mod Pathol."},{"issue":"3","key":"10.1016\/j.ijgc.2025.101635_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2559.1993.tb01194.x","article-title":"Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age","volume":"23","author":"Sloane","year":"1993","journal-title":"Histopathology"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T02:40:14Z","timestamp":1769913614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25001483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1048891X25001483"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101635","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101635"}}